Van Oene Mark sold $30K of PACB
Van Oene Mark (See Remarks) sold 26,911 shares of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) at $1.13 on 2026-08-17.
How this was made
The 30-second read
Why it matters
Traders may monitor insider activity as a sentiment input, but this specific disclosure is a small open-market sale and lacks additional fundamental catalysts in the text.
Market read
A newly filed insider sale can cause minor, short-term sentiment noise, but it is unlikely to drive a durable repricing without accompanying company news.
What to watch
The text does not confirm whether the sale was part of a 10b5-1 plan (it states 'No'), but it also provides no stated reason for the sale or any concurrent operational news.
Background
The article is an SEC Form 4 insider transaction disclosure for Pacific Biosciences of California, Inc. (PACB).
Ticker impact
PACB insider Van Oene Mark sold 26,911 shares in an open-market transaction for about $30.4K, per a fresh SEC Form 4 filing.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a Form 4 insider sale (not a buy), but the disclosed dollar value is relatively small and there is no 10b5-1 plan detail provided in the text.
Market effects
No sector-wide implication is disclosed; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
Insider sales are often pre-planned for diversification or tax needs, so the sale may not reflect negative fundamentals.
Key entities
- issuerPACB
Pacific Biosciences of California, Inc., the company whose insider transaction is disclosed.
- insiderVan Oene Mark
Officer at PACB who sold 26,911 shares at $1.1300/share.
